Nanthealth, inc. (NH)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16
Cash flows from operating activities:
Net Income (Loss) Attributable to Parent

-19,774

-62,762

-100,135

-181,224

-189,907

-192,152

-164,664

-109,596

-156,264

-175,211

-213,528

-208,004

-192,072

-184,102

0

0

0

Adjustments to reconcile net income (loss) to net cash used in operating activities:
Gain on sale of businesses

31,629

-582

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

20,814

22,362

23,412

23,415

22,877

22,355

21,253

22,503

25,021

28,055

31,231

31,893

31,455

30,933

0

0

0

Amortization of debt discounts and deferred financing offering cost

5,887

5,702

5,523

5,349

5,181

5,018

4,859

4,707

4,560

4,417

3,368

2,247

1,159

108

0

0

0

Change in fair value of derivatives liability

-5

0

0

5

6

7

26

27

50

264

1,473

1,467

1,443

1,228

0

0

0

Change in fair value of Bookings Commitment

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

Unrealized changes in fair value of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

49

0

0

0

Realized changes in fair value of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-49

0

0

0

Stock-based compensation

2,789

2,786

2,701

2,548

3,589

5,657

13,392

8,056

6,979

4,511

894

11,051

54,104

53,952

0

0

0

Deferred income taxes, net

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

Provision for bad debt expense

-71

-67

-117

-22

-19

7

206

75

69

220

182

195

626

549

0

0

0

Loss from related party equity method investment

-7,891

-8,317

-25,298

-106,621

-107,358

-108,409

-93,493

-13,129

-49,069

-50,334

-79,454

-79,116

-42,606

-40,994

0

0

0

Changes in operating assets and liabilities:
Accounts receivable, net

-4,265

-3,316

-5,252

-4,013

534

-406

1,140

5,523

3,694

-4

1,339

-6,564

-7,975

-8,111

0

0

0

Inventories

400

302

-452

-428

-389

-343

-320

-298

-188

-196

374

368

477

570

0

0

0

Related party receivables, net

-407

-687

-828

-477

-11

306

606

-295

-590

-623

-636

121

330

325

0

0

0

Prepaid expenses and other current assets

85

16,629

19,394

675

-632

-2,270

-1,584

-687

-658

588

1,882

-1,293

-3,518

-3,495

0

0

0

Accounts payable

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Deferred implementation costs

-

-

-

-

-

-48

230

676

1,749

2,214

1,208

1,341

3,028

5,952

0

0

0

Accounts payable

-

-

-

-

-

-1,667

-1,874

3,362

995

-1,852

-2,295

-4,816

-2,279

-5,644

0

0

0

Accrued and other current liabilities

2,621

17,425

18,400

-228

1,867

-4,822

-5,320

-7,090

-9,459

-6,321

-2,069

-2,829

1,633

3,787

0

0

0

Deferred revenue

2,587

5,036

14,006

14,946

18,551

16,947

0

0

0

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-277

3,853

0

0

0

Related party payables, net

6,171

5,961

4,778

4,820

5,033

6,026

5,738

390

2,729

2,832

4,050

8,641

9,761

4,220

0

0

0

Change in operating lease right-of-use assets and liabilities

-462

-418

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Other operating assets and liabilities

558

608

118

-1,099

-2,668

-3,066

-1,984

-747

109

290

-161

-156

465

73

0

0

0

Net cash used in operating activities

-6,675

-8,765

-9,733

-15,216

-21,172

-29,632

-34,026

-49,990

-68,419

-81,148

-91,956

-84,236

-65,158

-70,634

0

0

0

Cash flows from investing activities:
Proceeds from Divestiture of Businesses, Net of Cash Divested

46,701

300

232

232

-68

0

68

1,789

1,789

1,721

0

0

0

-

-

-

-

Acquisitions of businesses, net of cash acquired

-

-

-

-

-

-

-

-

-

-

-

-

-

78,725

0

0

0

Deferred consideration for acquisition

-

-

-

-

-

-

-

-

-

-

-

-

-

4,358

0

0

0

Purchases of property and equipment, including internal-use software

4,552

4,590

4,647

7,307

11,059

10,546

10,474

8,647

6,726

13,636

15,635

17,865

18,980

15,780

0

0

0

Purchases of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

31

0

0

0

Proceeds from sales of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

1,275

0

0

0

Net cash provided by (used in) investing activities

42,149

-4,290

-4,347

-7,007

-11,059

-10,478

-10,766

-7,218

-5,297

-12,275

-10,807

-14,549

-16,119

-88,765

0

0

0

Cash flows from financing activities:
Repayments of insurance promissory note

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from (payment of) related party promissory notes

-

-

-

-

-

-

-

-

-

-

-

-

-

152,666

0

0

0

Deemed capital contribution from Chairman and CEO

-

-

-

-

-

-

-

-

-

-

-

-

-

3,810

0

0

0

Tax payments related to stock issued, net of stock withheld, for vested equity awards

212

270

331

337

1,785

2,066

4,600

4,620

3,568

5,335

2,756

8,549

7,944

5,838

0

0

0

Payment of short-term notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

23,324

0

0

0

Net cash used in financing activities

-212

-32

615

-430

-1,878

-2,159

-4,693

-4,620

-3,568

-5,335

100,348

96,355

181,706

313,594

0

0

0

Effect of exchange rate changes on cash, cash equivalents and restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

169

0

0

0

Effect of exchange rate changes on cash, cash equivalents and restricted cash

11

25

-50

-30

-187

-300

0

0

0

-

0

0

0

-

-

-

-

Net increase (decrease) in cash, cash equivalents and restricted cash

35,273

-13,062

-13,515

-22,683

-34,296

-42,569

-49,866

-62,124

-77,368

-98,693

0

0

0

-

-

-

-

Net (decrease) increase in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

154,364

0

0

0

Supplemental disclosure of cash flow information
Interest paid

-

-

-

-

-

-

-

-

-

-

-

-

12

11

0

0

0

Interest received

-

-

-

-

-

13

12

36

55

63

73

54

127

119

0

0

0

Noncash investing and financing activities
Purchases of property and equipment including internal use software

-

-

-

-

-

-

0

0

0

-

2,806

3,825

4,604

2,962

0

0

0

NaviNet escrow receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Accretion to redemption value of Series F / redeemable common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

4,958

0

0

0